Disclosed positions

Estimated from their latest filings — positions may have changed since

$522.2K

combined est. value

Stock	Shares	Price	Value	Weight	As of
RXRXRECURSION PHARMACEUTICALS, INC.	135,981	$3.84	$522.2K	100%	2026-06-17

RXRX

RECURSION PHARMACEUTICALS, INC.

$522.2K

135,981 sh

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 0sells 0

Stock	Transaction	Date	~6mo later
RXRXRECURSION PHARMACEUTICALS, INC.	Grant — · 88,424 sh	2026-06-17	—
DVAXDYNAVAX TECHNOLOGIES CORP	Return — · 29,865 sh	2026-02-10	—
RXRXRECURSION PHARMACEUTICALS, INC.	Grant — · 11,008 sh	2025-06-18	—
DVAXDYNAVAX TECHNOLOGIES CORP	Grant — · 5,758 sh	2025-06-11	—

RXRXGrant

2026-06-17 · RECURSION PHARMACEUTICALS, INC.

88,424

—

DVAXReturn

2026-02-10 · DYNAVAX TECHNOLOGIES CORP

29,865

—

RXRXGrant

2025-06-18 · RECURSION PHARMACEUTICALS, INC.

11,008

—

DVAXGrant

2025-06-11 · DYNAVAX TECHNOLOGIES CORP

5,758

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.